"Medicome powstało w 2010 roku i stale się rozszerza, wprowadzając do swojej oferty nowe poradnie specjalistyczne. Pracują tu ambitni, cenieni i doświadczeni lekarze, którzy poza pracą z Pacjentami prowadzą badania kliniczne. Nad Państwa zdrowiem i komfortem czuwają tu również wykwalifikowane pielęgniarki oraz rejestratorki medyczne. Obiekt jest nowoczesny i dostosowany do potrzeb osób niepełnosprawnych, a jego wnętrza spełniają surowe normy stawiane placówkom medycznym. Co nas wyróżnia? Placówek medycznych jest wiele, ale my postanowiliśmy stworzyć miejsce, gdzie Pacjenci będą mieli dostęp do wysokospecjalistycznej opieki lekarskiej, świadczonej przez renomowanych lekarzy z wieloletnim doświadczeniem."

During the past decade, Medicome Sp. z o.o. conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 20 clinical trials were completed, i.e. on average, 46.5% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 13 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medicome Sp. z o.o." #1 sponsor was "Boehringer Ingelheim" with 10 trials, followed by "Pfizer" with 8 trials sponsored, "Kowa Research Institute, Inc." with 3 trials sponsored, "Arena Pharmaceuticals" with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medicome Sp. z o.o." #1 collaborator was "Eli Lilly and Company" with 5 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 3 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Dr. Falk Pharma GmbH" with 1 trials as a collaborator and "ICON plc" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Medicome Sp. z o.o." are "Ulcerative Colitis" (7 trials), "Diabetes Mellitus, Type 2" (4 trials), "Heart Failure" (3 trials), "Severe Hypertriglyceridemia" (3 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Medicome Sp. z o.o." in a lesser frequency.

Most popular intervention types in "Medicome Sp. z o.o." are "Drug" (45 trials), "Other" (3 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Etrasimod" (5 trials), "Empagliflozin" (3 trials), "K-877" (3 trials) and "BI 685509" (2 trials). Other intervention names were less common.

The vast majority of trials in "Medicome Sp. z o.o." are 44 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Medicome Sp. z o.o.". undefined are not yet recruiting, 11 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Medicome Sp. z o.o., 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Medicome Sp. z o.o., 0 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".